Jazz Pharmaceuticals (JAZZ) Curent Deferred Tax Liability (2012 - 2015)
Jazz Pharmaceuticals (JAZZ) posted quarterly Curent Deferred Tax Liability of $9.4 million for Q3 2015, up 50.46% year-over-year from $6.3 million in Q3 2014, and little changed quarter-over-quarter from $9.4 million in Q2 2015.
Jazz Pharmaceuticals (JAZZ) Curent Deferred Tax Liability (2012 - 2015) Analysis & Trends
Jazz Pharmaceuticals' Curent Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $9.4 million for Q3 2015.
- In Q3 2015, Curent Deferred Tax Liability rose 50.46% year-over-year to $9.4 million; the TTM figure through Sep 2015 stood at $9.4 million (up 50.46% YoY), while the FY2014 annual figure was $9.4 million, up 50.66% from the prior year.
- Curent Deferred Tax Liability for Q3 2015 stood at $9.4 million, roughly flat from $9.4 million in the prior quarter.
- The five-year high for Curent Deferred Tax Liability was $9.4 million in Q2 2015, with the low at $259000.0 in Q1 2013.
- The 4-year median for Curent Deferred Tax Liability is $6.3 million (2013), against an average of $5.3 million.
- The sharpest annual moves came in 2014 and 2015: Curent Deferred Tax Liability soared 2316.6% in 2014, then soared 50.46% in 2015.
- Jazz Pharmaceuticals' Curent Deferred Tax Liability stood at $275000.0 in 2012, then surged by 2176.0% to $6.3 million in 2013, then surged by 50.66% to $9.4 million in 2014, then dropped by 0.14% to $9.4 million in 2015.
- Business Quant data shows JAZZ's Curent Deferred Tax Liability at $9.4 million in Q3 2015, $9.4 million in Q2 2015, and $9.4 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 9.42 Mn |
| Sep 30, 2015 | 9.42 Mn |
| Jun 30, 2015 | 9.44 Mn |
| Jun 30, 2015 | 9.44 Mn |
| Mar 31, 2015 | 9.43 Mn |
| Mar 31, 2015 | 9.43 Mn |
| Dec 31, 2014 | 9.43 Mn |
| Dec 31, 2014 | 9.43 Mn |
| Sep 30, 2014 | 6.26 Mn |
| Sep 30, 2014 | 6.26 Mn |
| Jun 30, 2014 | 6.26 Mn |
| Jun 30, 2014 | 6.26 Mn |
| Mar 31, 2014 | 6.26 Mn |
| Mar 31, 2014 | 6.26 Mn |
| Dec 31, 2013 | 6.26 Mn |
| Dec 31, 2013 | 6.26 Mn |
| Sep 30, 2013 | 275,000.00 |
| Sep 30, 2013 | 275,000.00 |
| Jun 30, 2013 | 259,000.00 |
| Jun 30, 2013 | 259,000.00 |